Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Double-blind, Randomized, Placebo-controlled, Parallel-group Efficacy and Safety Study of LRG-002 Hard Capsules (Lek d.d., Slovenia) Used in the Prophylaxis of Antibiotic-associated Diarrhea in Adults.

NCT04321460 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.

NCT NCT04321460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04321460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Double-blind, Randomized, Placebo-controlled, Parallel-group Efficacy and Safety Study of LRG-002 Hard Capsules (Lek d.d., Slovenia) Used in the Prophylaxis of Antibiotic-associated Diarrhea in Adults.
Lead sponsor
Sandoz
Phase
Phase 3
Overall status
Completed
Start date
October 1, 2020
Completion date
January 4, 2021
Enrollment
520 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic-associated diarrhea